Latest Equities News

Wellnex Life Limited is exploring acquisition interest and convertible note funding to accelerate Pain Away's expansion and strengthen its financial footing, signaling a pivotal phase in its turnaround journey.

Western Mines Group has revealed a landmark nickel sulphide discovery at its Mulga Tank project in Western Australia, boasting 5.3 million tonnes of contained nickel and ranking among the world’s top 10 deposits.

Bhagwan Marine Ltd has announced a transformative $120 million acquisition of Riverside Marine Holdings, significantly enhancing its scale, profitability, and market reach. The deal is expected to lift FY26 revenue to $346 million and deliver a 14% EPS accretion.

Bhagwan Marine Limited has announced a transformative acquisition of Riverside Marine Holdings for up to $130 million, significantly boosting its scale, service diversity, and earnings potential.

PYC Therapeutics has initiated a substantial capital raising effort, aiming to secure up to A$653 million to propel its four RNA therapeutic candidates through critical clinical milestones. The retail entitlement offer opens today, following a successful institutional placement.

Argo Investments reported a striking 79% jump in half-year profit to $130.8 million, underpinned by stronger investment income, and announced an 18.5 cents per share fully franked interim dividend.

Future Generation Global Limited has announced a substantial 49% increase in its fully franked dividend for FY2025, alongside a special dividend, reflecting robust portfolio performance and a commitment to shareholder returns.

Challenger Limited confirms advanced discussions with Pepper Group to jointly acquire Pepper Money, aiming for strategic access to fixed income assets and accretive earnings.

DGR Global has been flagged by ASX for breaching Listing Rule 10.1 after advancing $500,000 without prior shareholder approval. The company is now preparing to seek retroactive approval and address further funding tranches.

News Corporation reported a 4% revenue increase to US$4.506 billion for the half-year ended December 2025, while net income declined 9% to US$305 million. The company declared an interim dividend and continued its stock repurchase program amid mixed segment performances and ongoing legal challenges.

Shares of Apiam Animal Health Limited (ASX – AHX) have been suspended from trading following court approval of its acquisition by entities controlled by Adamantem Capital Fund II. This marks a significant ownership change for the animal health company.

Conico Ltd is set to raise $85,000 through a follow-on share placement at $0.008 per share, targeting strategic shareholders to meet excess demand from its recent entitlement offer.